BIOMAT Database Logo BIOMAT Database Logo

Heme catabolism and heme oxygenase in neurodegenerative disease. 2004

Atsushi Takeda, and Yasuto Itoyama, and Teiko Kimpara, and Xiongwei Zhu, and Jesús Avila, and Barney E Dwyer, and George Perry, and Mark A Smith
Department of Neurology, Tohoku University School of Medicine, Sendai 980-8574, Japan. atakeda@em.neurol.med.tohoku.ac.jp

Heme oxygenase, the rate-limiting step in heme catabolism, appears to play an important role in a number of neurodegenerative disorders, such as Alzheimer disease. Interestingly, the spatial distribution of heme oxygenase-1 expression in diseased brain is essentially identical to that of the pathological expression of tau, suggesting a key role for both in disease progression. Like heme oxygenase, the expression, phosphorylation, and aggregation of tau are regulated through signal cascades, including the extracellular signal-regulated kinases, whose activities are modulated by oxidative stress. Therefore, the expression of tau and heme oxygenase-1 in a coordinated manner likely plays a pivotal role in the cytoprotection of neuronal cells. This places heme oxygenase at the center of disease pathogenesis and offers a novel therapeutic approach targeted at either the causes or consequences of enzyme induction.

UI MeSH Term Description Entries
D007501 Iron A metallic element with atomic symbol Fe, atomic number 26, and atomic weight 55.85. It is an essential constituent of HEMOGLOBINS; CYTOCHROMES; and IRON-BINDING PROTEINS. It plays a role in cellular redox reactions and in the transport of OXYGEN. Iron-56,Iron 56
D007527 Isoenzymes Structurally related forms of an enzyme. Each isoenzyme has the same mechanism and classification, but differs in its chemical, physical, or immunological characteristics. Alloenzyme,Allozyme,Isoenzyme,Isozyme,Isozymes,Alloenzymes,Allozymes
D011487 Protein Conformation The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain). Conformation, Protein,Conformations, Protein,Protein Conformations
D002248 Carbon Monoxide Carbon monoxide (CO). A poisonous colorless, odorless, tasteless gas. It combines with hemoglobin to form carboxyhemoglobin, which has no oxygen carrying capacity. The resultant oxygen deprivation causes headache, dizziness, decreased pulse and respiratory rates, unconsciousness, and death. (From Merck Index, 11th ed) Monoxide, Carbon
D006418 Heme The color-furnishing portion of hemoglobin. It is found free in tissues and as the prosthetic group in many hemeproteins. Ferroprotoporphyrin,Protoheme,Haem,Heme b,Protoheme IX
D006419 Heme Oxygenase (Decyclizing) A mixed function oxidase enzyme which during hemoglobin catabolism catalyzes the degradation of heme to ferrous iron, carbon monoxide and biliverdin in the presence of molecular oxygen and reduced NADPH. The enzyme is induced by metals, particularly cobalt. Haem Oxygenase,Heme Oxygenase,Oxygenase, Haem,Oxygenase, Heme
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D016875 tau Proteins Microtubule-associated proteins that are mainly expressed in neurons. Tau proteins constitute several isoforms and play an important role in the assembly of tubulin monomers into microtubules and in maintaining the cytoskeleton and axonal transport. Aggregation of specific sets of tau proteins in filamentous inclusions is the common feature of intraneuronal and glial fibrillar lesions (NEUROFIBRILLARY TANGLES; NEUROPIL THREADS) in numerous neurodegenerative disorders (ALZHEIMER DISEASE; TAUOPATHIES). tau Protein,Protein, tau,Proteins, tau
D019636 Neurodegenerative Diseases Hereditary and sporadic conditions which are characterized by progressive nervous system dysfunction. These disorders are often associated with atrophy of the affected central or peripheral nervous system structures. Degenerative Diseases, Nervous System,Degenerative Diseases, Central Nervous System,Degenerative Diseases, Neurologic,Degenerative Diseases, Spinal Cord,Degenerative Neurologic Diseases,Degenerative Neurologic Disorders,Nervous System Degenerative Diseases,Neurodegenerative Disorders,Neurologic Degenerative Conditions,Neurologic Degenerative Diseases,Neurologic Diseases, Degenerative,Degenerative Condition, Neurologic,Degenerative Conditions, Neurologic,Degenerative Neurologic Disease,Degenerative Neurologic Disorder,Neurodegenerative Disease,Neurodegenerative Disorder,Neurologic Degenerative Condition,Neurologic Degenerative Disease,Neurologic Disease, Degenerative,Neurologic Disorder, Degenerative,Neurologic Disorders, Degenerative

Related Publications

Atsushi Takeda, and Yasuto Itoyama, and Teiko Kimpara, and Xiongwei Zhu, and Jesús Avila, and Barney E Dwyer, and George Perry, and Mark A Smith
Heme catabolism by the reconstituted heme oxygenase system.
January 1976, Annals of clinical research,
Atsushi Takeda, and Yasuto Itoyama, and Teiko Kimpara, and Xiongwei Zhu, and Jesús Avila, and Barney E Dwyer, and George Perry, and Mark A Smith
Heme catabolism by heme oxygenase: physiology, regulation, and mechanism of action.
October 1988, Seminars in hematology,
Atsushi Takeda, and Yasuto Itoyama, and Teiko Kimpara, and Xiongwei Zhu, and Jesús Avila, and Barney E Dwyer, and George Perry, and Mark A Smith
Cimetidine induces hepatic heme oxygenase activity without altering hepatic heme catabolism.
August 1986, Experientia,
Atsushi Takeda, and Yasuto Itoyama, and Teiko Kimpara, and Xiongwei Zhu, and Jesús Avila, and Barney E Dwyer, and George Perry, and Mark A Smith
Heme oxygenase 1 in erythropoiesis: an important regulator beyond catalyzing heme catabolism.
June 2023, Annals of hematology,
Atsushi Takeda, and Yasuto Itoyama, and Teiko Kimpara, and Xiongwei Zhu, and Jesús Avila, and Barney E Dwyer, and George Perry, and Mark A Smith
Heme oxygenase in liver transplantation: heme catabolism and metabolites in the search of function.
August 2003, Hepatology (Baltimore, Md.),
Atsushi Takeda, and Yasuto Itoyama, and Teiko Kimpara, and Xiongwei Zhu, and Jesús Avila, and Barney E Dwyer, and George Perry, and Mark A Smith
Involvement of Heme Oxygenase-1 in Neuropsychiatric and Neurodegenerative Diseases.
January 2018, Current pharmaceutical design,
Atsushi Takeda, and Yasuto Itoyama, and Teiko Kimpara, and Xiongwei Zhu, and Jesús Avila, and Barney E Dwyer, and George Perry, and Mark A Smith
Alternative localization of HEME OXYGENASE 1 in plant cells regulates cytosolic heme catabolism.
May 2024, Plant physiology,
Atsushi Takeda, and Yasuto Itoyama, and Teiko Kimpara, and Xiongwei Zhu, and Jesús Avila, and Barney E Dwyer, and George Perry, and Mark A Smith
Heme catabolism by heme oxygenase-1 confers host resistance to Mycobacterium infection.
July 2013, Infection and immunity,
Atsushi Takeda, and Yasuto Itoyama, and Teiko Kimpara, and Xiongwei Zhu, and Jesús Avila, and Barney E Dwyer, and George Perry, and Mark A Smith
Targeting heme oxygenase-1 for neuroprotection and neuroinflammation in neurodegenerative diseases.
December 2010, Current drug targets,
Atsushi Takeda, and Yasuto Itoyama, and Teiko Kimpara, and Xiongwei Zhu, and Jesús Avila, and Barney E Dwyer, and George Perry, and Mark A Smith
Heme oxygenase and renal disease.
February 2009, Current hypertension reports,
Copied contents to your clipboard!